Considering the possible role of inflammatory molecules in the early detection of AD, in this study, we focused on evaluating the correlation between plasma levels of pro- and anti-inflammatory cytokines, chemokines, TTR, and amyloid species with cognitive functions/neuropsychiatric symptoms to provide a substrate for finding a potential early-stage detection marker for AD. Here, TTR is linked to Alzheimer disease.